Alpha-fetoprotein and serum Golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas

Hepatology

Volumn 50, Issue 1, 2009, Pages 326-

  Riener, Marc Oliver ^a   Stenner, Frank ^a   Liewen, Heike ^a   Hellerbrand, Claus ^b   Bahra, Marcus ^c   Kristiansen, Glen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; GOLGI PHOSPHOROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG; AFP PROTEIN, HUMAN; BIOLOGICAL MARKER; GOLM1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

CANCER EPIDEMIOLOGY; CANCER STAGING; DATA ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EARLY DIAGNOSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; BLOOD; CANCER DIAGNOSIS; GOLGI COMPLEX; LIVER TUMOR; NOTE;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; GOLGI APPARATUS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS;

EID: 67651162432     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23053     Document Type: Letter

References (1)

1. Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. HEPATOLOGY 2009;49:1602-1609.